As the use of GLP-1 RA expands, ongoing monitoring of side effects, especially those that are underrecognized in clinical settings, is essential for a better understanding of patient experiences and guiding future studies
L., Prancevic, S., Vissers, E., Campbell, J
Purity: 99% (HPLC)
Summary: Microdosing GLP-1 for Hashimoto's is an unapproved, off-label practice lacking clinical evidence, and the NHS does not recommend GLP-1 receptor agonists for thyroid conditions without concurrent type 2 diabetes or obesity meeting specific criteria
Remedy Meds was still on the list as a close second, but Josie felt like the better fit for her situationover 40, dealing with perimenopause, and looking for something that felt more tailored
Medication is prepared in a state-licensed pharmacy, and independently verified in FDA-registered labs